Cardiovascular

Compounds with research in cardiac protection, blood pressure, vascular function, or circulatory health. Showing 5 compounds.

← All categories
GHRP-6 Growth hormone releasing peptide studied in GH secretion and cardiac protection. View research notes → NAD+ Coenzyme studied in arterial stiffness, vascular function, and age-related decline. View research notes → Semaglutide FDA-approved GLP-1 agonist studied in weight reduction and cardiovascular outcomes. View research notes → TB-500 Thymosin beta-4 fragment studied in cardiac repair and vascular remodeling. View research notes → Tirzepatide FDA-approved dual GIP/GLP-1 agonist studied in weight loss and cardiovascular risk. View research notes → SS-31 (Elamipretide) SS-31 is a synthetic tetrapeptide belonging to the Szeto-Schiller (SS) family of mitochondria-targeted compounds, named for its developers Hazel Szeto and Peter Schiller. View research notes → Retatrutide Retatrutide is a synthetic peptide developed by Eli Lilly that acts as a single-molecule agonist at three distinct hormone receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor. View research notes →